The 5 most common treatment-emergent adverse events for the paliperidone palmitate treatment group were injection site pain ( 18.6 % of subjects ) , insomnia ( 16.8 % ) , weight increased ( 11.9 % ) , akathisia ( 11.1 % ) , and anxiety ( 10.6 % ) .